BIBW2992 in vitro PubMedCrossRef 27. Sekyi-Otu A, Bell RS, Ohashi C, Pollak M, Andrulis IL: Insulin-like growth factor 1 (IGF-1) receptors, IGF-1, and IGF-2 are expressed in primary human sarcomas. Cancer Res 1995, 55:129–134.PubMed 28. Valentinis B, Baserga R: IGF-I receptor signalling in transformation and differentiation. Mol Pathol 2001, 54:133–137.PubMedCrossRef 29. La Rocca G, Badin M, Shi B, Xu SQ, Deangelis T, Sepp-Lorenzinoi L, Baserga R: Mechanism of growth inhibition by MicroRNA 145: the role of the IGF-I receptor signaling pathway. J Cell Physiol 2009, 220:485–491.PubMedCrossRef 30. Cohen P, Lamson G, Okajima this website T, Rosenfeld RG: Transfection of the human insulin-like growth

factor binding protein-3 gene into Balb/c fibroblasts inhibits cellular growth. Mol Endocrinol 1993, 7:380–386.PubMedCrossRef Apoptosis antagonist 31. Rajah R, Valentinis B, Cohen P: Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis

and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism. J Biol Chem 1997, 272:12181–12188.PubMedCrossRef 32. Schedlich LJ, Young TF, Firth SM, Baxter RC: Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells. J Biol Chem 1998, 273:18347–18352.PubMedCrossRef 33. Singh B, Charkowicz D, Mascarenhas D: Insulin-like growth factor-independent effects mediated by a C-terminal metal-binding domain of insulin-like growth factor binding Cepharanthine protein-3. J Biol Chem 2004, 279:477–487.PubMedCrossRef 34. Prieur A, Tirode F, Cohen P, Delattre O: EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3. Mol Cell Biol 2004, 24:7275–7283.PubMedCrossRef 35. Riggi N, Suva ML, De Vito C, Provero

P, Stehle JC, Baumer K, Cironi L, Janiszewska M, Petricevic T, Suva D, Tercier S, Joseph JM, Guillou L, Stamenkovic I: EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells. Genes Dev 2010, 24:916–932.PubMedCrossRef 36. Larsson E, Fredlund Fuchs P, Heldin J, Barkefors I, Bondjers C, Genove G, Arrondel C, Gerwins P, Kurschat C, Schermer B, Benzing T, Harvey SJ, Kreuger J, Lindahl P: Discovery of microvascular miRNAs using public gene expression data: miR-145 is expressed in pericytes and is a regulator of Fli1. Genome Med 2009, 1:108.PubMedCrossRef 37. Haller F, von Heydebreck A, Zhang JD, Gunawan B, Langer C, Ramadori G, Wiemann S, Sahin O: Localization- and mutation-dependent microRNA (miRNA) expression signatures in gastrointestinal stromal tumours (GISTs), with a cluster of co-expressed miRNAs located at 14q32.31. J Pathol 2010, 220:71–86.PubMedCrossRef 38.